Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Posch Florian |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
John, N; Terbuch, A; Konjic, S; Absenger, G; Jost, PJ; Lindenmann, J; Fediuk, M; Sassmann, T; Wurm, R; Zacharias, M; Posch, F; Hochmaier, MJ; Fabikan, H; Weinlinger, C; Illini, O; Horvath, L; Gamerith, G; Pircher, A; Brcic, L
Prognostic impact of targetable driver alterations in resected early-stage lung cancer
WIEN KLIN WOCHENSCHR. 2024; 136(S13):S531-S531.-48. Jahrestagung ÖGP - 8th Jahrestagung OGTC; SEP 26-28, 2024; Vienna, Austria.
[Poster]
Web of Science
Schulz, E; Posch, F; Friedrich, K; Neumeister, P; Prochazka, K
Comparison of outcomes after DA-EPOCH-R or GMALL high-intensity therapy for frontline treatment of Burkitt lymphoma: A retrospective cohort
Oncol Res Treat. 2024; 47(Suppl2):307--Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; OCT 11-14, 2024; Basel, Switzerland.
[Poster]
FullText
Scholz, L; Posch, F; Schulz, E; Gornicec, M; Rosenkranz, AR; Schilcher, G; Krause, R; Hatzl, S
Ruxolitinib, Intravenous Immunoglobulin and High-Dose Corticosteroids in the Management of Critically Ill Adult Patients with Hemophagocytic Lymphohistiocytosis
41. Wiener Intensivmedizinische Tage ; FEB 15-18, 2023; Vienna, AUSTRIA. 2023.
[Oral Communication]
Scholz, L; Posch, F; Schulz, E; Gornicec, M; Rosenkranz, AR; Schilcher, G; Reisinger, A; Krause, R; Hatzl, S
Ruxolitinib, intravenous immunoglobulin and high-dose corticosteroids in the management of critically ill adult patients with hemophagocytic lymphohistiocytosis
MED KLIN-INTENSIVMED. 2023; 118(5):
[Oral Communication]
Web of Science
Muster, V; Raggam, RB; Urbanic-Purkart, T; Posch, F; Gutl, K; Rabensteiner, J; Pruller, F; von Campe, G; Rief, M; Brodmann, M; Gary, T
Lower-extremity deep vein thrombosis and bleeding complications in primary brain tumor patients: a prospective study
THROMB RES. 2022; 213: S16-S17.-11th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC); MAY 27-29, 2022; Bergamo, ITALY.
[Poster]
Web of Science
Muster, V; Raggam, RB; Urbanic-Purkart, T; Posch, F; Gutl, K; Rabensteiner, J; Pruller, F; von Campe, G; Rief, M; Brodmann, M; Gary, T
LOWER-EXTREMITY DEEP VEIN THROMBOSIS AND BLEEDING COMPLICATIONS IN PRIMARY BRAIN TUMOR PATIENTS: A PROSPECTIVE STUDY
NEURO-ONCOLOGY. Meeting Abstracts. 2022; 24(S2):-17th Meeting of the European-Association-of-Neuro-Oncology; SEP 15-18, 2022; Vienna, AUSTRIA.
Doi: 10.1093/neuonc/noac174.190
[Poster]
Web of Science
FullText
FullText_MUG
Muster, V; Raggam, RB; Urbanic-Purkart, T; Posch, F; Gütl, K; Rabensteiner, J; Prüller, F; von Campe, G; Rief, M; Brodmann, M; Gary, T
Lower-extremity deep vein thrombosis and bleeding complications in primary brain tumor patients: A prospective study
ICTHIC 2022; MAI 27-29, 2022; Bergamo, ITALY. 2022.
[Oral Communication]
Nemecz, V; Raggam, RB; Urbanic-Purkart, T; Posch, F; Gütl, K; Rabensteiner, J; Prüller, F; vonCampe, G; Rief, M; Brodmann, M; Gary, T
Lower-extremity deep vein thrombosis and bleeding complications in primary brain tumor patients: A prospective study
EANO 2022; Sept 15-18, 2022; Vienna, Austria. 2022.
[Poster]
Riedl, JM; Barth, D; Steinlechner, S; Moik, F; Posch, F; Schlintl, V; Mayer, MC; Sandner, AM; Berton, F; Koch, L; John, N; Wurm, R; Pichler, M; Absenger, G; Jost, PJ; Wohlkonig, C; Richtig, E; Winder, T; Gerger, A; Terbuch, A
Early CRP Kinetics after Initiation of Immune Checkpoint Inhibitors is a predictive Biomarker for Treatment Response independent of the Tumor Antity
ONCOL RES TREAT. 2022; 45(SUPPL 2):228-228.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; Okt 7-10, 2022; Wien.
[Poster]
Web of Science
Sadoghi, B; Posch, F; Tripolt, K; Komericki, P; Kränke, B; Hutterer, G
Ein multivariables Vorhersagemodell zur Identifizierung von Patient*innen, an einer sexuell übertragbaren Infektion zu erkranken.
webpublikation. 2022; -ÖGDV; NOV, 2022; Graz, AUSTRIA.
[Poster]
Scheipl, S; Brcic, I; Moser, T; Fischerauer, S; Riedl, J; Bergovec, M; Smolle, M; Posch, F; Gerger, A; Pichler, M; Stöger, H; Leithner, A; Heitzer, E; Liegl, B; Szkandera, J
Die molekularpathologische Testung von Weichteilsarkomen mittels FoundationOne® Heme bestätigt potentielle therapeutische Targets: Ergebnisse einer monozentrischen Analyse
Abstractband 1. Österreichischer Kongress für Orthopädie & Traumatologie. 2022; -1. Österreichischer Kongress für Orthopädie & Traumatologie; 12.-14. Mai, 2022; Graz, Austria.
[Poster]
Terbuch, A; Walser, G; Stotz, M; Gerger, A; Posch, F; Bauernhofer, T
Thromboprophylaxis and its influence on the risk of thromboembolism in patients with germ cell tumors receiving cisplatin-containing chemotherapy
ONCOL RES TREAT. 2022; 45(SUPPL 2):322-322.
[Poster]
Web of Science
Aramberri, M; Munoz-Guglielmetti, D; Pesantez, D; Posch, F; Ay, C; Beato, C; Diaz-Pedroche, C; Font, C
Short-term outcomes of cancer patients with pulmonary embolism according to the setting (hospital-acquired versus outpatient) at diagnosis in the era of incidental events
THROMB RES. 2021; 200: S53-S54.
[Onlinepräsentation]
Web of Science
Colling, M; Posch, F; Koder, S; Quehenberger, P; Ay, C; Pabinger, I; Gebhart, J
Renal Function and Risk of Arterial Thrombotic Events in Patients Positive for Lupus Anticoagulant
BLOOD. 2021; 138:
Doi: 10.1182/blood-2021-148365
Web of Science
FullText
FullText_MUG
Font, C; Posch, F; Ay, C; Aramberri, M; Pesantez, D; Munoz-Guglielmetti, D; Beato, C; Diaz-Pedroche, C
Performance of the '4S rule' to predict short-term outcomes in cancer outpatients with unsuspected pulmonary embolism
THROMB RES. 2021; 200: S66-S67.
[Onlinepräsentation]
Web of Science
Hatzl, M; Kalmar, P; Posch, F; Riedl, JM; Beham-Schmid, C; Prochazka, K; Greinix, H; Schwarz, T; Gstettner, G; Neumeister, P; Schulz, E
BASELINE TOTAL METABOLIC TUMOR VOLUME >220CM³ AND DEAUVILLE 5-POINT SCALE OF ≥4 AFTER FOUR CYCLES OF R-CHOP ARE STRONGLY ASSOCIATED WITH INFERIOR PROGRESSION FREE SURVIVAL IN PATIENTS WITH DLBCL
EHA Library. Hatzl S. 06/09/21; 325281; EP521.. 2021; -26th Congress of the European Hematology Association; JUNE 9-17,2021; virtual .
[Poster]
FullText
Klocker, EV; Posch, F; Suppan, C; Mischitz, N; Dengler, L; Steiner, D; Müller, HD; Jost, P; Dandachi, N; Balic, M
Histopathological features and prognosis of early lobular breast cancer
Oncology Research and Treatment, Vol. 44, Suppl. 2, 2021. 2021; -Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie ; OCT 1-4, 2021; Berlin, GERMANY.
[Poster]
Moik, F; van Es, N; Posch, F; Di Nisio, M; Fureder, T; Preusser, M; Pabinger, I; Ay, C
Evaluation of gemcitabine and platinum agents for the prediction of venous thromboembolism in patients with cancer: results from the Vienna Cancer and thrombosis Study
THROMB RES. 2021; 200: S68-S69.
[Poster]
Web of Science
FullText
Prinz, F; Reicher, A; Klec, C; Jonas, K; Posch, F; Pichler, M
miRNA mimics can artificially influence the expression of immune checkpoint molecules in biliary tract cancer.
Doctoral Day - Medical University of Graz; FEB 12, 2021; Graz, AUSTRIA. 2021.
[Onlinepräsentation]
Seles, M; Smolle, MA; Molnar, A; Riedl, JM;, Barth, DA; Terbuch, A, Rossmann, C; Mannweiler, S; Hutterer, GC, Zigeuner, R; Pummer, K; Smolle-Jüttner, FM; Lindenmann, J; Stotz, MA; gerger, A, Pichler, M; Posch, F.
Metastasektomie bei metachron metastasierten Nierenzellkarzinompatient*innen - Wer, wann & wie?
73. Kongress der Deutschen Gesellschaft für Urologie e.V.; SEp 15-18, 2021; Stuttgart, Germany. 2021.
[Oral Communication]
Smolle, M; Woelfel, J; Acem, I; Van De Sande, MAJ; Jeys, L; Bonekamp, H; Pollock, R; Keller, J; Tunn, PU; Haas, R; Van Ginkel, RJ; Verhoef, C; Posch, F; Liegl-Atzwanger, B; Moustafa-Hubmer, D; Jost, PJ; Leithner, A; Szkandera J
Neoadjuvant and adjuvant radiotherapy decreases the risk of local recurrence and adjuvant chemotherapy improves overall survival in a multicentre cohort of 2184 extremity soft tissue sarcoma patients
CTOS Abstract Book. 2021; -CTOS (Connective Tissue Oncology Society); NOV 10-13; Toronto, CANADA.
[Oral Communication]
Smolle, MA; Woelfel, J; Acem, I; van de Sande, M; Jeys, L; Bonekamp, H; Pollock, R; Keller, J; Tunn, PU; Haas, R; van Ginkel, RJ; Verhoef, C; Posch, F; Liegl-Atzwanger, B; Moustafa-Hubmer, D; Jost, P; Leithner, A; Szkandera, J
Effect of Neoadjuvant and Adjuvant Radiotherapy on Local Recurrence, Distant Metastasis, and Overall Survival in Extremity Soft Tissue Sarcoma.
Abstract Book of the EMSOS 2021. 2021; -EMSOS Annual Meeting 2021; DEC 1-3, 2021; Graz, AUSTRIA.
[Onlinepräsentation]
Suppan, C; Zhou, Q; Jahn, S; Graf, R; Klocker, EV; Terbuch, A; Kashofer, K; Posch, F; Gerritsmann, H; Dandachi, N; Heitzer, E; Balic, M
Comparison of liquid biopsy and tissue based detection of PIK3CAmutations in HR positive metastatic breast cancer patients
CANCER RES. 2021; 81(4):
[Poster]
Web of Science
Christoph Suppan, Qing Zhou, Stephan Jahn, Ricarda Graf, Eva Valentina Klocker, Angelika Terbuch, Karl Kashofer, Florian Posch, Hanno Gerritsmann, Nadia Dandachi, Ellen Heitzer, Marija Balic
Comparison of liquid biopsy and tissue based detection ofPIK3CAmutations in HR positive metastatic breast cancer patients.
SABCS 2020. 2020; -SABCS 2020; DEC 8-11, 2020; SAN ANTONIO, TEXAS, USA.
[Poster]
Gerger, A; Riedl, JM; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E
Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment trial.
ANN ONCOL. 2020; 31: S1095-S1096.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.08.1331
[Onlinepräsentation]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Moser, T; Waldispuehl-Geigl, J; Belic, J; Perakis, S; Weber, S; Zhou, Q; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Bauernhofer, T; Heitzer, E; Geigl, JB; Speicher, MR
Early circulating tumor DNA dynamics as a real-time predictor of FOLFOX efficacy in advanced colorectal cancer patients
CANCER RES. 2020; 80(16):
Doi: 10.1158/1538-7445.AM2020-4295
[Poster]
Web of Science
FullText
FullText_MUG
Moser, T; Waldispuehl-Geigl, J; Belic, J; Weber, S; Zhou, Q; Hasenleithner, S; Graf, R; Terzic, JA; Posch, F; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Bauernhofer, T; Heitzer, E; Geigl, JB; Speicher, MR
Real-time measurements of circulating tumor DNA levels during FOLFOX treatment in patients with colorectal cancer.
4th Annual Meeting of the ÖPPM; Vienna, AUSTRIA. 2020.
[Poster]
Posch, F; Barth, D; Brueckl, WM; Zeitler, G; Foris, V; Mollnar, S; Stotz, M; Rossmann, CH; Terbuch, A; Balic, M; Niedrist, T; Bertsch, T; Stoger, H; Pichler, M; Olschewski, H; Absenger, G; Ficker, JH; Gerger, A; Riedl, JM
C-reactive protein (CRP) levels in immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer: A bi-center study.
ANN ONCOL. 2020; 31: S286-S286.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.08.234
[Poster]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Prinz, F; Reicher, A; Klec, C; Jonas, K; Posch, F; Pichler, M
The influence of EMT-regulating microRNAs on immune checkpoint molecules.
9th Scientific Retreat of the DK-MCD; JAN 20-21, 2020; Seggau, AUSTRIA. 2020.
[Poster]
Prinz, F; Reicher, A; Klec, C; Jonas, K; Posch, F; Pichler, M
Artificial miRNA mimics can distort physiological miRNA effects on immune checkpoint molecule expression by triggering an unspecific interferon response.
10th Scientific Retreat of the DK-MCD; SEP 28-29, 2020; Graz, AUSTRIA. 2020.
[Oral Communication]
Prinz, F; Reicher, A; Klec, C; Jonas, K; Posch, F; Pichler, M
The influence of EMT-regulating microRNAs on immune checkpoint molecules.
9th Scientific Retreat of the DK-MCD; JAN 20-21, 2020; Seggau, AUSTRIA. 2020.
[Oral Communication]
Riedl, J; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E; Gerger, A
Individualized cancer treatment based on molecular profiling of circulating tumor DNA in patients with advanced and refractory carcinoma: a prospective phase II trial.
ONCOL RES TREAT. 2020; 43(SUPPL 4):249-249.-DGHO Jahrestagung; 09.10. -11.10.2020; Basel (virtueller Kongress).
[Oral Communication]
Web of Science
Riedl, J; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Schaberl-Moser, R; Stotz, M; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A
FOLFIRINOX versus Gemcitabine/nab-Paclitaxel as palliative first-line treatment of advanced pancreatic cancer: An Austrian observational Tri-Center comparative effectiveness analysis.
ONCOL RES TREAT. 2020; 43(SUPPL 4):215-215.
[Poster]
Web of Science
Riedl, JM; Posch, F; Gantschnigg, A; Horvath, L; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A
FOLFIRINOX versus Gemcitabine/nabPaclitaxel as First-line palliative Therapy in advanced Pancreatic Cancer: a Propensity-Score Analysis.
WIEN KLIN WOCHENSCHR. Abstracts 51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):78-79.-51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA.
[Poster]
Web of Science
Riedl, JM; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A
Gemcitabine/nab-paclitaxel versus (modified) FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
ANN ONCOL. 2020; 31: S942-S942.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.08.2013
[Poster]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Schwarzenbacher, E; Moik, F; Horvath, L; Renneberg, F; Posch, F; Barth, D; Gantschnigg, A; Schaberl-Moser, R; Pichler, M; Stotz, M; Stoger, H; Ay, C; Greil, R; Gerger, A; Djanani, A; Schlick, K; Riedl, J
Incidence, prediction and outcome of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of Gemcitabine/nab-Paclitxel or FOLFIRINOX.
ONCOL RES TREAT. 2020; 43(SUPPL 4):214-214.
[Poster]
Web of Science
Schwarzenbacher, E; Moik, F; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Ay, C; Stoger, H; Greil, R; Djanani, A; Gerger, A; Schlick, K; Riedl, JM
Patterns of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of gemcitabine/nab-paclitxel or FOLFIRINOX.
ANN ONCOL. 2020; 31: S949-S950.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.08.2035
[Poster]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Seles, M; Maisel, F; Smolle, M, Molnar, S; Riedl, JM; Barth, D; Terbuch, A; Rossman, CH; Mannweiler, S; Hutterer, GC; Zigeuner, RE; Pummer, K; Smolle-Jüttner, FM; Lindenmann, J; Stotz, M; Gerger, A; Stöger, H; Pichler, M; Posch, F
Hilfestellung zur sinnvollen Indikation der Metastasektomie bei metachron metastasierten Nierenzellkarzinompatienten.
German Medical Science. 2020; -46. Gemeinsame Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie; MAY, 14-16, 2020; Nuremberg, GERMANY..
[Onlinepräsentation]
FullText
Suppan, C; Steiner, D; Klocker, VE; Posch, F; Henzinger, EC; Stoeger, H; Dandachi, N; Balic, M
Safety and clinical evaluation of dual inhibition with pertuzumab and trastuzumab in HER-2-positive breast cancer patients.
J CLIN ONCOL. 2020; 38(15):
[Onlinepräsentation]
Web of Science
FullText
Aziz, F; Stelzl, A; Riedl, J; Smolle, M; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H
Diabetes is a predictor for survival in soft tissue sarcoma patients
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S477-S477.
[Poster]
Web of Science
Aziz, F; Stelzl, A; Riedl, JM; Smolle, MA; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H
Association of serum glucose levels with disease free survival in soft tissue sarcoma patients
DIABETOLOGIA. 2019; 62: S562-S563.-55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 16-20, 2019; Barcelona, SPAIN.
[Poster]
Web of Science
Balic, M; Suppan, C; Brcic, I; Tiran, V; Mueller, DH; Posch, F; Ulz, P; Heitzer, E; Dandachi, N
Untargeted assessment of tumour fractions in plasma for monitoring and prognostication from metastatic breast cancer patients undergoing systemic treatment
ANN ONCOL. 2019; 30: 110-+.-44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN.
[Poster]
Web of Science
Barth, D; Riedl, JM; Posch, F; Smolle, MA; Kasparek, AK; Niedrist, T; Szkandera, J; Stöger, H; Pichler, M; Gerger, A; Stotz, M
Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
Proceedings of the Annual Meeting of the Austrian Society
of Haematology and Medical Oncology. 2019; -OeGHO Frühjahrstagung 2019; APR 11-13; Linz, AUSTRIA.
[Poster]
Barth, DA; Riedl, JM; Foris, V; Posch, F; Mollnar, S; Stotz, M; Pichler, M; Stoger, H; Absenger, G; Olschewski, H; Gerger, A
External validation and longitudinal extension of the LIPI (lung immune prognostic index) for immunotherapy outcomes in advanced non-small cell lung cancer
ONCOL RES TREAT. 2019; 42: 108-108.
[Poster]
Web of Science
Coronel, DSP; Guglielmetti, DM; Posch, F; Ay, C; Aramberri, M; Zambrano, MDCB; Font, C
Performance of the '4S rule' to predict short-term outcomes in cancer outpatients with unsuspected pulmonary embolism
ANN ONCOL. 2019; 30: -44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN.
[Poster]
Web of Science
Dandachi, N; Suppan, C; Brcic, L; Tiran, V; Mueller, DH; Posch, F; Ulz, P; Heitzer, E; Balic, M
Monitoring therapy response and assessing prognosis by untargeted FAST-SeqS of circulating tumor DNA in metastatic breast cancer patients
ONCOL RES TREAT. 2019; 42: 41-41.
[Poster]
Web of Science
Glantschnig, T; Posch, F; Firla, S; Moik, F; Ablasser, K; Binder, JS; Stoschitzky, G; Wallner, M; Von Lewinski, D; Stoger, H; Zirlik, A; Pichler, M; Rainer, PP
Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+early breast cancer undergoing trastuzumab-based therapy
WIEN KLIN WOCHENSCHR. 2019; 131: 292-293.
[Poster]
Web of Science
Guglielmetti, DM; Pesantez, D; Posch, F; Ay, C; Aramberri, M; Zambrano, MDCB; Diaz-Pedroche, C; Font, C
Short-term outcomes of cancer patients with pulmonary embolism according to the setting (hospital-acquired vs. outpatient) at diagnosis
ANN ONCOL. 2019; 30: -44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN.
[Poster]
Web of Science
Leitner, L; Bratschitsch, G; Amerstorfer, F; Smolle, M; Posch, F; Leithner, A;
Challenges of Thesis Supervision in Medicine: How Candidates grade Organization and Didactics and what should be improved.
Symposium: Interprofessional Education in Health Sciences. 2019; -23nd Graz Conference; APR 26, 2019; Vienna. (ISBN: 978-3-200-06328-0 )
[Poster]
Pondorfer, P; Mollnar, S; Kasparek A; Reinisch, S; Moik, F; Stolz, M; Halm, M; Szkandera, J; Gerger; A; Kapp, K; Partl, R; Vasicek, S; Weiland, T; Pichler, M; Störer, H; Posch, F; Thurnher, D;
Induction chemotherapy and chemoradiation for patients with advanced HNSCC: A systematic analysis of acute treatment toxicities and their management
https://www.hno.at/fileadmin/userdaten/HNO_Kongress_2019/HNO2019_Abstractband_web_20190828.pdf. 2019; -Österreichischer HNO Kongress; Sep 11-15, 2019; Salzburg.
[Oral Communication]
FullText
Pondorfer, P; Molnar, S Kasparek, A.-K.; Reinisch, S; Moik, F; Stotz, M; Halm, M; Szkandera, J; Berger, A; Kapp, K.S;
Vasicek, S; Weiland, T; Pichler, M; Störer, H; Posch, F; Thurnher, D;
HPV infection as a predictive biomarker for response to induction chemotherapy and concomitant chemoradiation in patients with advanced head and neck squamous cell carcinoma
CEORL HNS; JUN 30, 2019; Brussels. 2019.
[Oral Communication]
FullText
Posch, F; Glantschnig, T; Firla, S; Smolle, M; Balic, M; Moik, F; Stoeger, H; Zirlik, A; Pichler, M; Rainer, P
Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+early breast cancer undergoing trastuzumab-based therapy
EUR HEART J. 2019; 40: 3844-3844.-ESC Congress / World Congress of Cardiology; AUG 31-SEP 04, 2019; Paris, FRANCE.
[Poster]
Web of Science
Prinz, F; Reicher, A; Kiesslich, T; Klec, C; Gerger, A; Stoeger, H; Posch, F; Pichler, M
The influence of epithelial-mesenchymal transition on immune checkpoint molecules in biliary tract cancer
OEGHO- & AHOP-Frühjahrstagung 2019; 11.-13.April 2019; Linz, AUSTRIA. 2019.
[Poster]
Prinz, F; Reicher, A; Kiesslich, T; Klec, C; Gerger, A; Stoeger, H; Posch, F; Pichler, M
Influence of epithelial-mesenchymal transition on immune checkpoints in biliary tract cancer
Doctoral Day of the Medical University Graz. 2019; -Doctoral Day of the Medical University Graz; NOV 21, 2019; Graz, AUSTRIA.
[Poster]
Reicher, A; Prinz, F; Klec, C; Stoeger, H; Moik, F; Posch, F; Pichler, M
Characterization of the fundamental role of fibroblast growth factor receptor 2 (FGFR2) gene fusions in carcinogenesis of intrahepatic cholangiocarcinoma using CRISPR/Cas9 genome engineering.
OEGHO- & AHOP-Frühjahrstagung 2019. 2019; -OeGHO- & AHOP-Frühjahrstagung 2019; 11.-13.April, 2019; Linz, AUSTRIA.
[Poster]
Riedl, J; Posch, F; Prager, G; Eisterer, W; Ohler, L; Thamer, S; Wilthoner, K; Petzer, A; Pichler, P; Hubmann, E; Winder, T; Burgstaller, S; Korger, M; Andel, J; Greil, R; Pecherstorfer, M; Philipp-Abbrederis, K; Djanani, A; Gruenberger, B; Langle, F; Woll, E; Gerger, A
The AST/ALT (De Ritis) ratio predicts clinical outcome in pancreatic cancer patients treated with first-line nab-paclitaxel and gemcitabine: post-hoc analysis of an Austrian multicenter, non-interventional study
ANN ONCOL. 2019; 30: -European-Society-for-Medical-Oncology (ESMO) 21st World Congress on Gastrointestinal Cancer; JUL 03-06, 2019; Barcelona, SPAIN.
Doi: 10.1093/annonc/mdz155.285
[Poster]
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Riedl, J; Stelzl, A; Aziz, F; Smolle, M; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stöger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Sourij, H; Szkandera, J
Elevated mean glucose level predicts decreased disease free survival in soft tissue sarcoma patients.
32nd Annual Meeting of the European Musculo Skeletal Oncology Society. 2019; -32nd Annual Meeting of the European Musculo Skeletal Oncology Society; MAY 15-17, 2019; Florence, ITALY .
[Poster]
FullText
Riedl, JM; Barth, D; Posch, F; Foris, V; Absenger, G; Mollnar, S; Pichler, M; Stotz, M; Stoger, H; Olschewski, H; Gerger, A
Longitudinal C-reactive protein (CRP) trajectories predict immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer
ONCOL RES TREAT. 2019; 42: 115-115.
[Poster]
Web of Science
Riedl, JM; Barth, DA; Foris, V; Posch, F; Mollnar, S; Stotz, M; Pichler, M; Stoger, H; Absenger, G; Olschewski, H; Gerger, A
External validation and longitudinal extension of the LIPI (Lung Immune Prognostic Index) for immunotherapy outcomes in advanced non-small cell lung cancer
ANN ONCOL. 2019; 30: -44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN.
[Poster]
Web of Science
Riedl, JM; Stelzl, A; Aziz, F; Smolle, MA; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stöger, H; Liegl-Atzwanger, B; Stotz,M; Gerger, A; Sourij, H; Szkandera, J
Elevated mean glucose level predicts decreased disease free survival in soft tissue sarcoma patients.
OeGHO- & AHOP-Frühjahrstagung 2019; 11.04.2019 - 13.04.2019; Linz, Austria. 2019.
[Oral Communication]
Scheipner, L; Smolle, MA; Barth, D; Posch, F; Stotz, M; Pichler, M; Stöger, H; Gerger, A; Riedl, JM
The AST/ALT ratio (de ritis) is an independent prognostic marker for disease free survival in stage II and III colorectal cancer
OeGHO- & AHOP-Frühjahrstagung 2019; 11.04.2019 - 13.04.2019; Linz, AUSTRIA. 2019.
[Oral Communication]
Seles, M; Fillafer, F; Posch, F; Terzic, J; Pichler, M; Hutterer, GC; Zigeuner, R; Pummer, K; Bauernhofer, T.
Lymphopenia can help to predict response to targeted 1st-line therapy in patients with metastatic renal cell carcinoma.
Europ Urolog Supplements. 2019; -Prize Winner Session at 34th Annual Congress of the European Association of Urology.; MAR 15-19; Bracelona, SPAIN.
[Oral Communication]
Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Niedersuss-Beke, D; Tinchon, C; Loidl, W; Pichler, M; Jahn, S; Stoger, H; Bauernhofer, T;
Lymphopenia impairs response to 1st-line tyrosine kinase inhibitor therapy in patients with metastatic clear-cell renal cell carcinoma and modulates the relative efficacy of sunitinib and pazopanib
WIEN KLIN WOCHENSCHR. 2019; 131: S447-S447.-Frühjahrstagung der OeGHO; APR 11-13, 2019; Linz, AUSTRIA.
[Poster]
Web of Science
FullText
Balic, M; Mueller, DH; Hammer, R; Gumpoldsberger, M; Suppan, C; Posch, F; Stoeger, H; Dandachi, N; Prein, K; Hauser, H; Lax, S
Independent evaluation of prognostic value of residual cancer burden (RCB) score on disease free and overall survival of breast cancer patients treated with neoadjuvant systemic treatment at a single institution
CANCER RES. 2018; 78(4):-San Antonio Breast Cancer Symposium; DEC 05-09, 2017; San Antonio, TX.
[Poster]
Web of Science
Grilz, E; Mauracher, LM; Konigsbrugge, O; Posch, F; Lang, I; Pabinger, I; Ay, C
The Role of Neutrophil Extracellular Traps in Cancer-Associated Arterial Thrombosis
BLOOD. 2018; 132:
Doi: 10.1182/blood-2018-99-116104
Web of Science
FullText
FullText_MUG
Grilz, E; Posch, F; Konigsbrugge, O; Marosi, C; Pabinger, I; Ay, C
Neutrophil-to-Lymphocyte Ratio and the Risk of Venous Thromboembolism and Mortality in Patients with Cancer
THROMB RES. 2018; 164: S232-S233.-9th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC); APR 13-15, 2018; Bergamo, ITALY.
Doi: 10.1016/j.thromres.2018.02.112
[Poster]
Web of Science
FullText
FullText_MUG
Klocker, EV; Stotz, M; Posch, F; Stojakovic, T; Stoeger, H; Kornprat, P; Gerger, A; Pichler, M
A high AST/ALT (De Ritis)-Ratio represents a poor prognostic factor in a large cohort of patients with pancreatic cancer.
OeGHO Frühjahrstagung 2018; APR 19-21, 2018; Villach, AUSTRIA. 2018.
[Poster]
Klöckl, MC; Kasparek, AK; Riedl, J; Moik ,F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer T; Stöger H; Posch, F
Estimated versus measured glomerular filtration rate to
evaluate kidney function in patients with cancer undergoing
cisplatin-based chemotherapy
Oncology Research
and Treatment . 2018; 41(Suppl4):224-224.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 )
[Poster]
Web of Science
FullText
Leithner, A; Posch, F; Smolle, MA; Willegger, M; Tunn, PU; Goldenitsch, E; Liegl-Atzwanger B; Döller, C; Windhager, R; Szkandera, J
Rethinking the follow-up of soft tissue sarcomas: a multicenter analysis of 835 cases.
Special APMSTS 2018 Issue of Journal of Bone and Soft Tissue Tumors. 2018; 4(2):-12th Asian Pacific Musculoskeletal Tumour Society (APMSTS) Meeting; OCT 4 -7, 2018; Jaipur, INDIA.
[Oral Communication]
Leithner, A; van Praag, V; Posch, F; Bergovec, M; Leitner, L; Friesenbichler, J; Heregger, R; Smolle-Juttner, FM; Fiocco, M; van de Sande, M; Riedl, J; Pichler, M; Gerger, A; Szkandera, J; Stoger, H; Liegl-Atzwanger, B; Smolle, MA
Efficacy of metastasectomy on survival in patients with metachronous soft tissue sarcoma-metastasis: Results of a bi-centre study including 135 patients
ANN ONCOL. Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany. 2018; 29(S8):-43rd ESMO Congress (ESMO); OCT 19-23, 2018; Munich, GERMANY.
[Poster]
Web of Science
Leithner, A;Smolle, MA; Szkandera, J; Posch, F; Liegl-Atzwanger, B; Scheipl, S; Bergovec, M
Spezialisierte Tumororthopädie.
Innovative, multimodale Therapiekonzepte bei Sarkomen; FEB 28, 2018; Vienna, AUSTRIA. 2018.
[Oral Communication]
Mollnar, S; Pondorfer, P; Reinisch, S; Moik, F; Halm, M; Kasparek, AK; Klockl, MC; Stotz, M; Szkandera, J; Gerger, A; Vasicek, S; Weiland, T; Pichler, M; Stoger, H; Thurnher, D; Posch, F
Definitive chemoradiotherapy with or without induction chemotherapy for unresectable squamous cell carcinoma of the head & neck: a propensity-score analysis
ONCOL RES TREAT. 2018; 41: 248-248.
[Poster]
Web of Science
Muller, HD; Posch, F; Gumpoldsberger, M; Suppan, C; Hammer, R; Hauser, H; Dandachi, N; Prein, K; Stoger, H; Lax, S; Balic, M
Prognostic impact of the Residual Cancer Burden (RCB) index on recurrence-free survival of breast cancer patients recieving neoadjuvant therapy
ONCOL RES TREAT. 2018; 41: 297-298.
[Poster]
Web of Science
Nazari, PMS; Riedl, J; Preusser, M; Posch, F; Thaler, J; Marosi, C; Birner, P; Ricken, G; Hainfellner, JA; Pabinger, I; Ay, C
The combination of podoplanin expression levels and IDH1 mutation status predicts VTE risk in patients with brain tumors
THROMB RES. 2018; 164: S195-S195.-9th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC); APR 13-15, 2018; Bergamo, ITALY.
Doi: 10.1016/j.thromres.2018.02.038
[Oral Communication]
Web of Science
FullText
FullText_MUG
Pertl, L; Mossböck, G; Wedrich, A; Weger, M; Königsbrügge, O; Posch, F
Triglyzeride und Offenwinkelglaukom - eine Metaanalyse.
Spektrum Augenheilkd. 2018; 32(2):70--59. Jahrestagung der Österreichischen Ophthalmologischen Gesellschaft; MAY 10-12, 2018; Schladming, AUSTRIA.
[Oral Communication]
Rejto, J; Schuster, G; Feistritzer, C; Quehenberger, P; Posch, F; Gebhart, J; Ay, C; Pabinger, I
Correlation of factor levels with bleeding phenotype in non-severe hemophilia
HAEMOPHILIA. 2018; 24: 93-93.
[Poster]
Web of Science
Seles, M; Fillafer, F; Posch, F; Pichler, M; Terzic, J; Mischinger, J; Hutterer, G; Zigeuner, R; Pummer, K; Bauernhofer, T
Lymphopenie als Prädiktor bei TKI-Erstlinientherapie des metastasierten klarzelligen Nierenzellkarzinoms
Der Urologe 2018, 57 (Suppl 1):S25/26.. 2018; -70. Kongress der Deutschen Gesellschaft für Urologie e.V.; 26.-29.09.2018; Messe Dresden, Deutschland.
[Oral Communication]
Seles, M; Fillafer, F; Posch, F; Terzic, J; Pichler, M; Hutterer, GC; Zigeuner, R; Pummer, K; Bauernhofer, T
Lymphopenia can help to predict response to targeted 1st-line therapy in patients with metastatic clear-cell renal cell carcinoma
Central European Meeting/European Association of Urology.; OCT 11-12,2018.; Cluj,ROMANIA.. 2018.
[Poster]
Seles, M; Fillhafer, F; Posch, F; Terzic, J; Pichler, M; Hutterer, G; Zigeuner, R; Pummer, K; Bauernhofer, T
Lymphopenie als Vorhersageparameter bei targeted Erstlinientherapie des metastasierten klarzelligen Nierenzellkarzinoms
German Medical Science GMS Publishing House;2018. Doc18urobay051. doi: 10.3205/18urobay051. 2018; -
44. Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie
; 14.-16.06.2018; Rosenheim, Deutschland.
[Oral Communication]
Smolle, MA; Bergovec, M; Posch, F; Szkandera, J; Liegl-Atzwanger, B; Smolle-Jüttner, FM; van de Sande, M; Leithner, A
Metastasektomie bei Weichteilsarkomen.
8th Annual Meeting of the Austrian Musculo-Skeletal Oncology Society; DEC 7, 2018; Wiener Neustadt, AUSTRIA. 2018.
[Oral Communication]
Smolle, MA; Tunn, PU; Goldenitsch, E; Posch, F; Szkandera, J; Bergovec, M; Liegl-Atzwanger, B; Leithner, A
Influence of unplanned excisions on overall-survival in patients with soft tissue sarcoma. Results of a multicentre-study including 728 patients.
Special APMSTS 2018 Issue of Journal of Bone and Soft Tissue Tumors. 2018; 4(2):-12th Asian Pacific Musculoskeletal Tumour Society (APMSTS) Meeting; OCT, 4-7, 2018; Jaipur, INDIA.
[Oral Communication]
Smolle, MA; Tunn, PU; Goldenitsch, E; Posch, F; Szkandera, J; Bergovec, M; Liegl-Atzwanger, B; Leithner, A
Outcome following unplanned excision in soft tissue sarcoma: Results of a multicentre study including 728 patients
ANN ONCOL. Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany. 2018; 29(S8):-43rd ESMO Congress (ESMO); OCT 19-23, 2018; Munich, GERMANY.
[Oral Communication]
Web of Science
Smolle, MA; van Praag, V; Posch, F; Bergovec; M; Leitner, L; Friesenbichler, J; Heregger, R; Smolle-Jüttner, FM; Fiocco, M; van de Sande, M; Riedl, J; Pichler, M; Gerger, A; Szkandera, J; Stöger, H; Liegl-Atzwanger, B; Leithner, A
Effect of metastasectomy on overall-survival of patients with
metachronous metastasis of STS. A bi-centre study including
135 patients.
12th Asian Pacific Musculoskeletal Tumour Society (APMSTS) Meeting; OCT 4-7, 2018; Jaipur, INDIA. 2018.
[Poster]
Smolle, MA; van Praag, V; Posch, F; Bergovec, M; Szkandera, J; Liegl-Atzwanger, B; van de Sande, M; Leithner, A
Einfluss der Metastasektomie auf das Überleben von Patienten mit metastasiertem Weichteilsarkom. Resultate einer Bi-Center Studie.
Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU); OCT 23-26, 2018; Berlin, GERMANY. 2018.
[Oral Communication]
Smolle, MA; Van Praag, VM; Posch, F; Bergovec, M; Heregger, R; Szkandera, J; Liegl-Atzwanger, B; Smolle-Jüttner, FM; van de Sande, MA; Leithner, A.
Metastasectomy in soft tissue sarcoma is associated with a post-metastasis survival benefit. Results from a bi-center study including 135 patients.
Final Program of the 2018 CTOS Annual Meeting. 2018; 435--CTOS Annual Meeting; NOV 14-17, 2018; Rome, ITALY.
[Poster]
Smolle, MA; van Praag, VM; Posch, F; Bergovec, M; Leitner, L; Friesenbichler, J; Heregger, R; Riedl, JM; Pichler, M; Gerger, A; Szkandera, J; Stöger, H; Smolle-Jüttner, FM; Liegl-Atzwanger, B; Fiocco, M; van de Sande, MAJ; Leithner, A
Metachronous metastasis of soft tissue sarcoma: Benefit of metastasectomy. A bi-centre study.
Abstractbook of the EMSOS 2018. 2018; -31st EMSOS Meeting; MAY 9-11, 2018; Amsterdam, THE NETHERLANDS.
[Oral Communication]
Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Pichler, M; Jahn, S; Stöger, H; Bauernhofer, T
Lymphopenia impairs response to 1st-line therapy with
sunitinib and pazopanib in patients with metastatic clear-cell
renal cell carcinoma.
Oncology Research
and Treatment . 2018; 41(Suppl4):42-43.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie,; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 )
[Oral Communication]
Web of Science
FullText
Balic, M; Mueller, HD; Hammer,R; Gumpoldsberger, M; Suppan,C; Posch,F; Stoeger, H; Dandachi, N; Prein, K; Hauser, H; Lax, S;
Independent evaluation of prognostic value of residual cancer burden (RCB) score on disease free and overall survival of breast cancer patients treated with neoadjuvant systemic treatment at a single institution
Proceedings of the 40th San Antonio Breast Cancer Symposium Abstracts2View™ Portal. 2017; -SABACS; DEC 5-9 2017; San Antonio, USA.
[Poster]
FullText
Bezan, A; Pasch, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Zurl, B; Kapp, K; Stager, H; Gerger, A; Stotz, M
Clinical characterization of febrile neutropenia episodes in patients with testicular germ cell tumors.
J CLIN ONCOL. 2017; 35: -53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET; JUN 02-07, 2017; Chicago, IL.
Doi: 10.1200/JCO.2017.35.15_suppl.e16038
[Oral Communication]
Web of Science
FullText
FullText_MUG
Leithner, A; Posch, F; Leitner, L; Liegl-Atzwanger, B; Pichler, M; Gerger, A; Bergovec, M; Szkandera, J
Local Recurrence, Distant Metastasis, and Death in Patients with Soft Tissue Sarcoma after Curative Resection Using a Multi-state Model.
Abstractbook of 19th General Meeting of ISOLS. 2017; -ISOLS 2017; MAY 10-12, 2017; Kanazawa, JAPAN.
[Oral Communication]
Leitner, L; Posch, F; Liegl-Atzwanger, B; Döller, C; Friesenbichler, J; Bergovec, M; Leithner, A; Szkandera, J;
Evaluierung der Wirksamkeit von adjuvanter Bestrahlung auf Lokalrezidiv-Rate, Metastasierung und Gesamtüberleben von Patienten mit lokalisierten Weichteilsarkomen.
Abstractbook des DKOU 2017 in Berlin. 2017; -DKOU Berlin; OCT 24-27, 2017; Berlin, GERMANY.
[Oral Communication]
Leitner, L; Posch, F; Liegl-Atzwanger, B; Pichler, M; Gerger, A; Bergovec, M; Leithner, A; Szkandera, J;
Lokalrezidiv-Rate, Metastasierung und Mortalität nach Resektion lokalisierter Weichteilsarkome in kurativer Intention: Ein multi-state Model.
Abstractbook des DKOU 2017 in Berlin. 2017; -DKOU Berlin; OCT 24-27, 2017; Berlin, GERMANY.
[Oral Communication]
Lindenmann, J; Fink-Neuboeck, N; Fediuk, M; Gschwandtner, E; Strießnig, A; Swatek, P; Pichler, M; Posch, F; Stacher-Priehse, E; Anegg, U; Maier, A; Smolle-Juettner, FM
PREDICTION OF CLINICAL OUTCOMES IN STAGE I NON-SMALL CELL LUNG CANCER AFTER CURATIVE SURGERY FOCUSING ON THE PREOPERATIVE GLASGOW PROGNOSTIC SCORE AND INFLAMMATORY BIOMARKERS.
Book of Abstracts of the 25th European Conference on General Thoracic Surgery. 2017; 214-215.-25th European Conference on General Thoracic Surgery; MAY 28-31, 2017; Innsbruck, AUSTRIA.
[Oral Communication]
FullText
Lindenmann, J; Fink-Neuboeck, N; Fediuk, M; Gschwandtner, E; Strießnig, A; Swatek, P; Pichler, M; Posch, F; Stacher-Priehse, E; Anegg, U; Maier, A; Smolle-Juettner, FM
HOW LONG SHOULD WE FOLLOW-UP PATIENTS WITH STAGE I NON-SMALL CELL LUNG CANCER AFTER CURATIVE RESECTION? AN ANALYSIS OF 300 CASES USING FLEXIBLE PARAMETRIC MODELING OF TUMOR RECURRENCE AND MORTALITY RATES.
Book of Abstracts of the 25th European Conference on General Thoracic Surgery. 2017; 166-167.-25th European Conference on General Thoracic Surgery; MAY 28-31, 2017; Innsbruck, AUSTRIA.
[Poster]
FullText
Partl R, Bezan A, Posch F, Zurl B, Bauernhofer T, Pichler M, Szkandera J, Hutterer G, Pummer K, Kapp KS, Stöger H, Gerger A, Stotz M
Untersuchung von Risikofaktoren für die Entwicklung einer febrilen Neutropenie nach cisplatinhältiger Chemotherapie bei Patienten mit testikulären Keimzelltumoren.
Konferenzsband. 2017; -34. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und Medizinische Radiophysik; OCT 5-6; Linz, AUSTRIA.
[Oral Communication]
Partl R, Posch F, Döller C, Riedl JM, Smolle M, Leitner L, Bergovec M, Liegl-Atzwanger B, Stotz M, Bezan A, Gerger A, Pichler M, Kapp KS, Stöger H, Leithner A, Szkandera J
Untersuchung des Benefits der adjuvanten Radiotherapie in Bezug auf Lokalkontrolle, Fernmetastasierung und Überleben bei PatientInnen mit lokalisiertem Weichteilsarkom mittels vergleichender Effektivitätsanalyse
Abstractband. 2017; -34. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und Medizinische Radiophysik ; OCT 6-7; Linz, AUSTRIA.
[Poster]
Posch, F;
Therapie-assoziierte Komplikationen bei Patienten mit Hodenkrebs - Erfahrungen aus der GOTEKA Kohorte
OeGHO Frühjahrstagung; APR 6-8, 2017; Bregenz, Austria. 2017.
[Oral Communication]
FullText
Posch, F; Alic, L; Koder, S; Gebhart, J; Ay, C; Binder, CJ; Pabinger, I
IgM Antibodies against Oxidation-specific Epitopes Identify Patients with a Lupus Anticoagulant at Risk for Thrombotic Complications: The Vienna Lupus Anticoagulant and Thrombosis Study
Research and Practice in Thrombosis and Haemostasis. Special Issue: Abstracts of the XXVI Congress of the International Society on Thrombosis and Haemostasis, July 8-13, 2017. 2017; 1(S1):47-48.-ISTH Bi-Annual Meeting 2017; JUL 8-13, 2017; Berlin, GERMANY.
[Oral Communication]
FullText
Posch, F; Ay, C; Kreutz, R; Beyer-Westendorf, J
Vitamin-K-antagonist oral anticoagulants and kidney function decline in patients with atrial fibrillation and chronic kidney disease
WIEN KLIN WOCHENSCHR. 2017; 129: S121-S121.
Web of Science
Posch, F; Silina, K; Petrausch, U; Leibl, S; Muendlein, A; Moch, H; Siebenhuener, AR; Pestalozzi, BC; Riedl, JM; Stotz, M; Szkandera, J; Stoeger, H; Pichler, M; Stupp, R; Schraml, P; Gerger, A; Winder, T;
The maturation stage of tumoral tertiary lymphoid structures to predict recurrence risk in localized colorectal cancer.
Journal of Clinical Oncology. 2017; 35 (15_suppl): e15083-e15083.-American Society of Clinical Oncology (ASCO) Annual Meeting; JUN 2-6, 2017; Chicago, IL, USA.
FullText
Posch, Florian; Riedl, Jakob; Leitner, Lukas; Liegl-Atzwanger, Bernadette; Doeller, Carmen; Bezan, Angelika; Stotz, Michael; Pichler, Martin; Gerger, Armin; Bergovec, Marko; Stoeger, Herbert; Leithner, Andreas; Szkandera, Joanna
Benefit of adjuvant radiotherapy for local control, distant metastasis, and survival outcomes in patients with localized soft tissue sarcoma: Comparative effectiveness analysis of an observational cohort study.
Proceedings of the 30th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS), A-0001. 2017; 89--30th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS); APR 26-28, 2017; Budapest, HUNGARY.
[Oral Communication]
Seles, M; Posch, F; Pichler, GP; Gary, T; Pummer, K; Zigeuner, R; Pichler, M, Hutterer, GC.
Kleine Thrombozyten im peripheren Blut repräsentieren einen prognostisch ungünstigen Faktor bezogen auf das klinische Outcome in einer PatientInnen-Kohorte mit nicht-metastasiertem Nierenzellkarzinom
German Medical Science GMS Publishing House.doi: 10.3205/17oegu021. 2017; -43. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayerischen Urologenvereinigung; MAY 16-18, 2017; Vienna, Austria.
[Oral Communication]
FullText
Seles, M; Stojakovic, B; Hager, B; Posch, F; Bezan, A; Pummer, K; Zigeuner, R; Pichler, M; Hutterer GC.
Evaluierung des prognostischen Einflusses der präoperativen Zahl eosinophiler Granulozyten im peripheren Blut auf das klinische Outcome in einer PatientInnen-Kohorte mit nicht-metastasiertem klarzellligen Nierenzellkarzinom
German Medical Science GMS Publishing House; 2017. Doc17oegu022. 2017; -43. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayerischen Urologenvereinigung; MAY 16-18, 2017; Vienna, Austria.
[Oral Communication]
FullText
Smolle, MA; Bergovec, M; Szkandera, J; Posch, F; Liegl-Atzwanger, B; Leithner, A
Behandlung von Patienten mit metastasiertem Weichteilsarkom
34. Jahrestagung der Österreichischen Gesellschaft für Orthopädie und orthopädische Chirurgie; NOV 30 - DEZ 1, 2017; Vienna, AUSTRIA. 2017.
[Oral Communication]
Smolle, MA; Tunn, PU; Goldenitsch, E; Posch, F; Szkandera, J; Bergovec, M; Liegl-Atzwanger, B; Leithner, A
Why Should Unplanned Excisions Best Be Avoided In Soft-Tissue Sarcomas? Results Of A Multi-Centre Study Including 728 Patients.
Abstractbook of 18th EFORT. 2017; -18th EFORT Congress; MAY 31 - JUN 2, 2017; Vienna, AUSTRIA.
[Oral Communication]
Smolle, MA; Tunn, PU; Goldentisch E; Posch, F; Szkandera, J; Bergovec, M; Liegl-Atzwanger, B; Leithner, A
Welche prognostische Bedeutung haben ungeplante Resektionen bei Weichteilsarkomen? Resultate einer multizentrischen, retrospektiven Studie mit 728 operativ versorgten Weichteilsarkom-Patienten.
Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU); OCT 24-27, 2017; Berlin, GERMANY. 2017.
[Oral Communication]
Beyer-Westendorf, J; Kreutz, R; Posch, F; Ay, C
The CHA2DS2-VASc score strongly correlates with glomerular filtration rate and predicts decline in renal function over time in patients with atrial fibrillation and chronic kidney disease
EUR HEART J. 2016; 37: 604-604.-Congress of the European-Society-of-Cardiology (ESC); AUG 27-31, 2016; Rome, ITALY.
[Oral Communication]
Web of Science
Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Beyer, J; Winder, T; Hermanns, T; Fankhauser, CD; Gerger, A; Stotz, M
Risk stratification for venous thromboembolism in patients with testicular germ cell tumors
ÖGHO; March 17-19, 2016; Wien. 2016.
[Oral Communication]
Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Gerger, A; Stotz, M;
23 Risk stratification for venous thromboembolism in patients with testicular germ cell tumours
European Urology Supplements. 2016; 15(3):E23--European Association of Urology (EAU) Annual Meeting; MAR 11-15, 2016; Munich, GERMANY.
[Oral Communication]
FullText
Posch, F
Statistics for Thrombo-Oncologists
ISTH SSC; MAY 25-28, 2016; Montpellier, FRANCE. 2016.
[Oral Communication]
Posch, F;
Therapie Krebs-assoziierter Thrombosen - "prime time" für NOAKs/DOAKs?
OeGHO Frühjahrstagung; MAR 17-19, 2016; Vienna, Austria. 2016.
[Oral Communication]
FullText
Posch, F;
Therapierelevante Laborparameter in der Onkologie und deren Bedeutung
AHOP Frühjahrstagung; MAR 17-19, 2016; Vienna, Austria. 2016.
[Oral Communication]
FullText
Posch, F; Leitner, L; Liegl-Atzwanger, B; Wink, A; Stotz, M; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J
Benefit of adjuvant radiotherapy for local control, distant metastasis, and survival outcomes in patients with localized soft tissue sarcoma: Comparative effectiveness analysis of an observational cohort study
Abstracts of CTOS 2016. 2016; -CTOS (Connective Tissue Oncology Society); Nov 9-12; Lisbon, PORTUGAL.
[Oral Communication]
Posch, F; Leitner, L; Stotz, M; Liegl-Atzwanger, B; Bezan, A; Pichler, M; Friesenbichler, J; Gerger, A; Stoeger, H; Leithner, A; Szkandera, J
Conditional survival of patients with soft tissue sarcoma (STS) after curative resection
Abstracts of CTOS 2016. 2016; -CTOS (Connective Tissue Oncology Society); NOV 9-12; Lisbon, PORTUGAL.
[Poster]
Posch, F; Leitner, L; Stotz, M; Liegl-Atzwanger, B; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J
Local recurrence, distant metastasis, and death in patients with soft tissue sarcoma (STS) after curative resection: A multi-state model
Abstracts of CTOS 2016. 2016; -CTOS (Connective Tissue Oncology Society); NO 9-12; Lisbon, PORTUGAL.
[Poster]
Posch, F; Liegl-Atzwanger, B; Thalhammer, M; Stotz, M; Bezan, A; Mrsic, E; Samonigg, H; Pichler, M; Gerger, A; Szkandera, J
Local recurrence, distant metastasis, adjuvant imatinib, and long-term survival outcomes in patients with gastrointestinal-stroma-tumors (GIST) after curative surgery: A multi-state model
ÖGHO; MARCH, 17-19, 2016; WIEN. 2016.
[Oral Communication]
Riedl, J; Posch, F; Stotz, M; Bezan, A; Winder, T; Schaberl-Moser, R; Pichler, M; Stoeger, H; Gerger, A
Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK.
Doi: 10.1093/annonc/mdw370.107
[Poster]
Web of Science
FullText
FullText_MUG
Silina, K; Petrausch, U; Posch, F; Leibl, S; Mundlein, A; Moch, H; Siebenhuner, A; Stupp, R; Riedl, J; Pestalozzi, BC; Schraml, P; Gerger, A; Winder, T
Comprehensive molecular and immunological analysis to assess the tumor immune contexture in stage II and III colorectal cancer
ANN ONCOL. 2016; 27:
Doi: 10.1093/annonc/mdw393.12
Web of Science
FullText
FullText_MUG
Smolle, MA; Goldenitsch, E; Machacek, F; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J
THERAPY AND OUTCOME OF PATIENTS FOLLOWING UNPLANNED EXCISIONS IN SOFT TISSUE SARCOMA: A MULTI- CENTRE EXPERIENCE.
Abstracts of CTOS 2016; P2-P185. 2016; -CTOS 2016; NOV 9-12, 2016; Lisbon, PORTUGAL.
[Poster]
Smolle, MA; Posch, F; Szkandera, J; Bergovec, M; Leithner, A
Der Einfluss von ungeplanten Resektionen auf das Überleben von Patienten mit Weichteilsarkomen: Eine retrospektive Datenanalyse.
33. Jahrestagung Österreichische Gesellschaft für Orthopädie und Orthopädische Chirurgie; SEP 29 - OCT 1, 2016; Villach, AUSTRIA. 2016.
[Oral Communication]
Szkandera, J; Posch, F; Stotz, M; Liegl-Atzwanger, B; Pichler, M; Gerger, A; Friesenbichler, J; Leithner, A
Local recurrence, distant metastasis, and death in patients with soft tissue
sarcoma (STS) after curative resection: A multi-state model.
Abstracts of EMSOS 2016. 2016; -29th Annual Meeting of the European Musculo-Skeletal Oncology Society; MAY 25-27, 2016; La Baule, FRANCE.
[Oral Communication]
Szkandera, J; Posch, F; Stotz, M; Liegl-Atzwanger, B; Pichler, M; Gerger, A; Friesenbichler, J; Leithner, A
Conditional survival of patients with soft tissue sarcoma (STS) after curative
Resection.
Abstracts of EMSOS 2016. 2016; -29th Annual Meeting of the European Musculo-Skeletal Oncology Society; MAY 25-27, 2016; La Baule, FRANCE.
[Oral Communication]
Winder, T; Posch, F; Asamer, E; Stotz, M; Siebenhuner, A; Schlick, K; Magnes, T; Samaras, P; Szkandera, J; Clavien, PA; Neureiter, D; Greil, R; Pestalozzi, BC; Stoeger, H; Gerger, A; Egle, A; Pichler, M
An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK.
Doi: 10.1093/annonc/mdw371.77
[Poster]
Web of Science
FullText
FullText_MUG
Ay, C; Posch, F; Riedl, J; Koenigsbruegge, O; Quehenberger, P; Zielinski, C; Pabinger, I
Prediction of Venous Thromboembolism in Patients with Cancer By the Activated Partial Thromboplastin Time: Results from the Vienna Cancer and Thrombosis Study.
Abstracts of the 57th ASH Annual Meeting. 2015; 126(23):653-653.-American Society of Hematology (ASH) Annual Meeting; DEC 5-8, 2015; Orlando, FL, USA.
[Oral Communication]
FullText
Gebhart, J; Posch, F; Koder, S; Perkmann, T; Quehenberger, P; Zoghlami, C; Ay, C; Pabinger, I
Increased mortality in patients with the lupus anticoagulant: the Vienna lupus anticoagulant and thrombosis study (LATS)
Journal of Thrombosis & Haemostasis (JTH) Special Issue: Abstracts of the XXV Congress of the International Society on Thrombosis and Haemostasis, June 20–25, 2015. 2015; 13(S2):11-12.-International Society of Thrombosis & Haemostasis (ISTH) Congress 2015; JUN 20-25, 2015; Toronto, CANADA.
[Oral Communication]
FullText
Hell, L; Ay, C; Posch, F; Koder, S; Gebhart, J; Pabinger, I; Thaler, J
Low microparticle-associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosis.
Journal of Thrombosis & Haemostasis (JTH) Special Issue: Abstracts of the XXV Congress of the International Society on Thrombosis and Haemostasis, June 20–25, 2015. 2015; 13(S2):892--International Society of Thrombosis & Haemostasis (ISTH) Congress 2015; JUN 20-25, 2015; Toronto, CANADA.
[Poster]
FullText
Posch, F
Paraneoplastische und Katheter-assoziierte Thrombosen
Intensivkurs Angiologie; OCT 23-24, 2015; Dresden, GERMANY. 2015.
[Oral Communication]
FullText
Posch, F
Thromboembolierisiko unter Chemotherapie
Intensivkurs Angiologie; OCT 23-24, 2015; Dresden, GERMANY. 2015.
[Oral Communication]
FullText
Posch, F; Gebhart, J; Rand, Jacob H.; de Laat, B; Koder, S; Quehenberger, P; Ay, C; Pabinger, I
Thrombotic Events in Lupus Anticoagulant Positive Patients Prospectively Correlate with Clinical Risk Factors - the Vienna Lupus Anticoagulant and Thrombosis Study (LATS).
Abstracts of the 57th ASH Annual Meeting. 2015; 126(23):652-652.-American Society of Hematology (ASH) Annual Meeting; DEC 5-8, 2015; Orlando, FL, USA.
[Oral Communication]
FullText
Posch, F; Gebhart, J; Wu, X; Koder, S; Ay, C; Rand, JH; Pabinger, I
Annexin A5 Resistance Is Associated with Thrombotic Risk in Patients with the Lupus Anticoagulant: The Vienna Lupus Anticoagulant and Thrombosis Study (LATS).
Abstracts of the 57th ASH Annual Meeting. 2015; 126(23):3555-3555.-American Society of Hematology (ASH) Annual Meeting; DEC 5-8, 2015; Orlando, FL, USA.
[Poster]
FullText
Posch, F; Koenigsbruegge, O; Zielinski, C; Pabinger, I; Ay, C
A network meta-analysis comparing the efficacy and safety of anticoagulants for the treatment of venous thromboembolism in cancer patients.
Journal of Thrombosis & Haemostasis (JTH) Special Issue: Abstracts of the XXV Congress of the International Society on Thrombosis and Haemostasis, June 20–25, 2015.. 2015; 133(S2):193--International Society of Thrombosis & Haemostasis (ISTH) Congress 2015; JUN 20-25, 2015; Toronto, CANADA.
[Oral Communication]
FullText
Posch, F; Reitter, EM; Riedl, J; Pabinger, I; Ay, C
Hypercoagulability, venous thromboembolism and death in patients with cancer: a multi-state model
Journal of Thrombosis & Haemostasis (JTH) Special Issue: Abstracts of the XXV Congress of the International Society on Thrombosis and Haemostasis, June 20–25, 2015. 2015; 13(S2):181--Journal of Thrombosis & Haemostasis (JTH) Special Issue: Abstracts of the XXV Congress of the International Society on Thrombosis and Haemostasis, June 20–25, 2015; JUN 20-25, 2015; Toronto, CANADA.
[Oral Communication]
FullText
Riedl, J; Preusser, M; Posch, F; Marosi, C; Birner, P; Thaler, J; Hainfellner, J; Pabinger, I; Ay, C
Podoplanin expression and intravascular platelet aggregates: the missing link between cancer and thrombosis in primary malignant brain tumors
Journal of Thrombosis & Haemostasis (JTH) Special Issue: Abstracts of the XXV Congress of the International Society on Thrombosis and Haemostasis, June 20–25, 2015. 2015; 133(S2):232--International Society of Thrombosis & Haemostasis (ISTH) Congress 2015; JUN 20-25, 2015; Toronto, CANADA.
[Oral Communication]
FullText
Posch, F; Ay, C; Kaider, A; Zielinski, C; Pabinger, I
Estimating rates of venous thromboembolism in patients with cancer using the Kaplan-Meier and competing-risk approach: insights from the Vienna Cancer and Thrombosis Study.
Thrombosis Research, Volume 133, Supplement 2, Pages S1-S228.. 2014; 190-190.-7th International Conference on Thrombosis and Hemostasis Issues in Cancer; MAY 9-11, 2014; Bergamo, ITALY.
[Poster]
FullText
Riedl, J; Kaider, A; Posch, F; Koder, S; Reitter, EM; Marosi, C; Zielinski, C; Pabinger, I; Ay, C;
Association of soluble CD40 ligand and thrombospondin-1 with cancer-associated venous thromboembolism.
Thrombosis Research, Volume 133, Supplement 2, Pages S1-S228. 2014; 205-206.-7th International Conference on Thrombosis and Hemostasis Issues in Cancer; MAY 9-11, 2014; Bergamo, ITALY.
[Poster]
FullText